ArticleScientific reports2014

Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.

Jian-Ming Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.